Great Lakes Advisors, LLC Amgen Inc Transaction History

Great Lakes Advisors, LLC

$11.1 Billion
Q3 2024

A detailed history of Great Lakes Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 319,921 shares of AMGN stock, worth $84.3 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

319,921

Previous 325,093 1.59%

Holding current value

$84.3 Million

Previous $102 Million 1.48%

% of portfolio

0.93%

Previous 0.96%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$309.38 - $337.38 $1.6 Million - $1.74 Million	-5,172 Reduced 1.59%	319,921 $103 Million
Q2 2024 Aug 05, 2024	SELL	$262.75 - $319.31 $8.2 Million - $9.97 Million	-31,221 Reduced 8.76%	325,093 $102 Million
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $6.77 Million - $8.17 Million	25,177 Added 7.6%	356,314 $101 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $19.3 Million - $21.7 Million	-75,351 Reduced 18.54%	331,137 $95.4 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $82.6 Million - $103 Million	377,870 Added 1320.39%	406,488 $109 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $386,971 - $457,586	-1,806 Reduced 5.94%	28,618 $6.35 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $2.14 Million - $2.61 Million	-9,470 Reduced 23.74%	30,424 $7.36 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $1.7 Million - $2.17 Million	7,442 Added 22.93%	39,894 $10.5 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $1.54 Million - $1.74 Million	-6,865 Reduced 17.46%	32,452 $7.32 Million
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $4.49 Million - $5 Million	19,461 Added 98.01%	39,317 $9.57 Million
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $301,715 - $333,776	1,376 Added 7.45%	19,856 $4.8 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $175,213 - $200,515	881 Added 5.01%	18,480 $4.16 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $18,892 - $22,134	-89 Reduced 0.5%	17,599 $3.74 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $66,103 - $73,336	283 Added 1.63%	17,688 $4.31 Million
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $53,924 - $62,839	243 Added 1.42%	17,405 $4.33 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $153,197 - $182,430	708 Added 4.3%	17,162 $3.95 Million
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $116,151 - $129,170	495 Added 3.1%	16,454 $4.18 Million
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $38,177 - $46,848	-193 Reduced 1.19%	15,959 $3.76 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $88,021 - $116,741	483 Added 3.08%	16,152 $3.27 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $43,329 - $55,692	229 Added 1.48%	15,669 $3.78 Million
Q3 2019 Nov 06, 2019	BUY	$174.11 - $208.62 $23,853 - $28,580	137 Added 0.9%	15,440 $2.99 Million
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $163,199 - $191,306	-979 Reduced 6.01%	15,303 $2.82 Million
Q1 2019 May 07, 2019	SELL	$180.87 - $203.88 $507,521 - $572,087	-2,806 Reduced 14.7%	16,282 $3.09 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $172,691 - $201,586	968 Added 5.34%	19,088 $3.72 Million
Q3 2018 Nov 30, 2018	BUY	$185.29 - $208.89 $2.91 Million - $3.28 Million	15,683 Added 643.54%	18,120 $3.76 Million
Q3 2018 Nov 15, 2018	SELL	$185.29 - $208.89 $2.03 Million - $2.29 Million	-10,964 Reduced 81.81%	2,437 $505,000
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $215,698 - $242,276	-1,299 Reduced 8.84%	13,401 $2.47 Million
Q1 2018 May 07, 2018	SELL	$169.43 - $198.0 $52.7 Million - $61.6 Million	-311,031 Reduced 95.49%	14,700 $2.51 Million
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $15.9 Million - $17.7 Million	94,073 Added 40.61%	325,731 $56.6 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $38.8 Million - $44.2 Million	231,658	231,658 $43.2 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.

Account

Great Lakes Advisors, LLC Amgen Inc Transaction History